137 related articles for article (PubMed ID: 36858501)
1. [Insulin-derived amyloidosis (insulin ball) and skin-related complications of insulin therapy].
Nagase T; Iwaya K; Zako T; Kikuchi M; Katsura Y
Nihon Yakurigaku Zasshi; 2023; 158(2):173-177. PubMed ID: 36858501
[TBL] [Abstract][Full Text] [Related]
2. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
Ansari AM; Osmani L; Matsangos AE; Li QK
Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of insulin-derived amyloidosis: a case report.
Iwaya K; Zako T; Fukunaga J; Sörgjerd KM; Ogata K; Kogure K; Kosano H; Noritake M; Maeda M; Ando Y; Katsura Y; Nagase T
BMC Endocr Disord; 2019 Jun; 19(1):61. PubMed ID: 31196059
[TBL] [Abstract][Full Text] [Related]
4. Insulin-derived amyloidosis and poor glycemic control: a case series.
Nagase T; Iwaya K; Iwaki Y; Kotake F; Uchida R; Oh-i T; Sekine H; Miwa K; Murakami S; Odaka T; Kure M; Nemoto Y; Noritake M; Katsura Y
Am J Med; 2014 May; 127(5):450-4. PubMed ID: 24462809
[TBL] [Abstract][Full Text] [Related]
5. Nodular amyloidosis at the sites of insulin injections.
Bernárdez C; Schärer L; Molina-Ruiz AM; Requena L
J Cutan Pathol; 2015 Jul; 42(7):496-502. PubMed ID: 25953111
[TBL] [Abstract][Full Text] [Related]
6. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
Richardson T; Kerr D
Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
[TBL] [Abstract][Full Text] [Related]
7. Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks.
Huang J; Yeung AM; Kerr D; Gentile S; Heinemann L; Al-Sofiani ME; Joseph JI; Seley JJ; Klonoff DC
Endocr Pract; 2023 Aug; 29(8):670-677. PubMed ID: 37098370
[TBL] [Abstract][Full Text] [Related]
8. Why and by How Much is Insulin Absorption Reduced by Insulin-derived Amyloidosis? A Scoping Review.
Ibuki A; Fukuda M; Akase T; Sugama J; Yanagita T
Yakugaku Zasshi; 2023; 143(10):865-870. PubMed ID: 37779016
[TBL] [Abstract][Full Text] [Related]
9. Prevention of lipohypertrophy.
Kalra S; Kumar A; Gupta Y
J Pak Med Assoc; 2016 Jul; 66(7):910-1. PubMed ID: 27427150
[TBL] [Abstract][Full Text] [Related]
10. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
[TBL] [Abstract][Full Text] [Related]
11. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010.
Ji J; Lou Q
Curr Med Res Opin; 2014 Jun; 30(6):1087-93. PubMed ID: 24552616
[TBL] [Abstract][Full Text] [Related]
12. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus.
Arora S; Agrawal NK; Shanthaiah DM; Verma A; Singh S; Patne SCU; Kalra S; Singh P; Goyal S
Prim Care Diabetes; 2021 Oct; 15(5):859-864. PubMed ID: 34154931
[TBL] [Abstract][Full Text] [Related]
13. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study.
Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195
[TBL] [Abstract][Full Text] [Related]
14. Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
Luo D; Shi Y; Zhu M; Wang H; Yan D; Yu J; Ji J; Liu X; Fan B; Xu Y; Zhang M; He W; Xu J; Yang T
J Diabetes Complications; 2021 Mar; 35(3):107806. PubMed ID: 33280982
[TBL] [Abstract][Full Text] [Related]
15. Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates.
Mori W; Yuzu K; Lobsiger N; Nishioka H; Sato H; Nagase T; Iwaya K; Lindgren M; Zako T
Sci Rep; 2021 Mar; 11(1):6857. PubMed ID: 33767265
[TBL] [Abstract][Full Text] [Related]
16. Differences in clinicopathological characteristics between lipohypertrophy and localized insulin-derived amyloidosis: A scoping review.
Mukai K; Tanno H; Sugama J; Yanagita T; Kanno E
Chronic Dis Transl Med; 2024 Mar; 10(1):22-30. PubMed ID: 38450303
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
Hauner H; Stockamp B; Haastert B
Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
[TBL] [Abstract][Full Text] [Related]
18. Errors in insulin treatment management and risk of lipohypertrophy.
Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
[TBL] [Abstract][Full Text] [Related]
19. Diabetic lipohypertrophy delays insulin absorption.
Young RJ; Hannan WJ; Frier BM; Steel JM; Duncan LJ
Diabetes Care; 1984; 7(5):479-80. PubMed ID: 6389062
[TBL] [Abstract][Full Text] [Related]
20. Localized Insulin-Derived Amyloidosis in Diabetes Mellitus Type 1 Patient: A Case Report.
Hrudka J; Sticová E; Krbcová M; Schwarzmannová K
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
